Jacqueline Douglass
7PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 16, 2026
Lethal toxin-equipped effector cells for the potential treatment of cancer.Alexander H Pearlman, Brian J Mog, Michael S Hwang
|Dec 22, 2025
TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.Jiaxin Ge, Joshua Urban, Sarah R DiNapoli
|Jul 10, 2024
Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.Brian J Mog, Nikita Marcou, Sarah R DiNapoli
|Sep 07, 2021
Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.Michael S Hwang, Michelle S Miller, Puchong Thirawatananond
|Mar 02, 2021
TCR β chain-directed bispecific antibodies for the treatment of T cell cancers.Suman Paul, Alexander H Pearlman, Jacqueline Douglass
|Mar 02, 2021
Targeting a neoantigen derived from a common TP53 mutation.Emily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass
Pageof 2
Frequent Collaborators
7 joint publications
Sarah R DiNapoli
7 joint publications
Suman Paul
7 joint publications
Maximilian F Konig
6 joint publications
Nickolas Papadopoulos
6 joint publications
Brian J Mog
6 joint publications
Alexander H Pearlman
6 joint publications
Bert Vogelstein
6 joint publications
Drew M Pardoll
6 joint publications
Shibin Zhou
5 joint publications
Katharine M Wright
